Literature DB >> 22403306

Efficacy of artemether-lumefantrine in area of high malaria endemicity in India and its correlation with blood concentration of lumefantrine.

Neena Valecha1, Suman Mohanty, Prakriti Srivastava, Surya Sharma, Prajesh Tyagi, Yngve Bergqvist, Pascal Ringwald.   

Abstract

This study was conducted to correlate blood concentrations of lumefantrine with treatment outcome for patients with Plasmodium falciparum malaria when the drug was given without specific instructions for administration with food. Patients with P. falciparum malaria in the highly endemic state of Orissa, India, were enrolled during 2008 and followed-up for 28 days after admistration of artemether-lumefantrine for three days according to a World Health Organization protocol. Drug concentration in whole blood was determined by using blood spots placed on filter paper on day 7. The technology is suitable for field studies. One hundred percent of the patients had an adequate clinical and parasitological response. These results confirm the efficacy of artemether-lumefantrine in persons from poor tribal communities when given without specific instructions regarding co-administration with food, despite high inter-individual variability in blood concentrations of lumefantrine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22403306      PMCID: PMC3284351          DOI: 10.4269/ajtmh.2012.11-0182

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.

Authors:  N A Kshirsagar; N J Gogtay; N S Moorthy; M R Garg; S S Dalvi; A R Chogle; J S Sorabjee; S N Marathe; G H Tilve; A D Bhatt; S P Sane; R Mull; I Gathmann
Journal:  Am J Trop Med Hyg       Date:  2000-03       Impact factor: 2.345

2.  Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.

Authors:  Mey Bouth Denis; Reiko Tsuyuoka; Pharath Lim; Niklas Lindegardh; Poravuth Yi; Sophoan Narann Top; Duong Socheat; Thierry Fandeur; Anna Annerberg; Eva Maria Christophel; Pascal Ringwald
Journal:  Trop Med Int Health       Date:  2006-12       Impact factor: 2.622

3.  Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria.

Authors:  F Ezzet; M van Vugt; F Nosten; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

Authors:  N J White; M van Vugt; F Ezzet
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

5.  How much fat is necessary to optimize lumefantrine oral bioavailability?

Authors:  Elizabeth A Ashley; Kasia Stepniewska; Niklas Lindegårdh; Anna Annerberg; Am Kham; Al Brockman; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Trop Med Int Health       Date:  2007-02       Impact factor: 2.622

6.  Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.

Authors:  Patrice Piola; Carole Fogg; Francis Bajunirwe; Samuel Biraro; Francesco Grandesso; Eugene Ruzagira; Joseph Babigumira; Isaac Kigozi; James Kiguli; Juliet Kyomuhendo; Laurent Ferradini; Walter Taylor; Francesco Checchi; Jean-Paul Guthmann
Journal:  Lancet       Date:  2005 Apr 23-29       Impact factor: 79.321

7.  Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper.

Authors:  D Blessborn; S Römsing; A Annerberg; D Sundquist; A Björkman; N Lindegardh; Y Bergqvist
Journal:  J Pharm Biomed Anal       Date:  2007-07-20       Impact factor: 3.935

8.  Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.

Authors:  Ric N Price; Anne-Catrin Uhlemann; Michele van Vugt; Al Brockman; Robert Hutagalung; Shalini Nair; Denae Nash; Pratap Singhasivanon; Tim J C Anderson; Sanjeev Krishna; Nicholas J White; François Nosten
Journal:  Clin Infect Dis       Date:  2006-04-26       Impact factor: 9.079

9.  Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia.

Authors:  Christine Manyando; Rhoda Mkandawire; Lwipa Puma; Moses Sinkala; Evans Mpabalwani; Eric Njunju; Melba Gomes; Isabela Ribeiro; Verena Walter; Mailis Virtanen; Raymond Schlienger; Marc Cousin; Miriam Chipimo; Frank M Sullivan
Journal:  Malar J       Date:  2010-09-01       Impact factor: 2.979

10.  Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.

Authors:  Neena Valecha; Prakriti Srivastava; Suman S Mohanty; Pooja Mittra; Surya K Sharma; Prajesh K Tyagi; Khageswar Pradhan; Vas Dev; Ruchi Singh; Aditya P Dash; Yagya D Sharma
Journal:  Malar J       Date:  2009-05-19       Impact factor: 2.979

View more
  1 in total

1.  PCR targeting Plasmodium mitochondrial genome of DNA extracted from dried blood on filter paper compared to whole blood.

Authors:  Gro E A Strøm; Sabrina Moyo; Maulidi Fataki; Nina Langeland; Bjørn Blomberg
Journal:  Malar J       Date:  2014-04-07       Impact factor: 2.979

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.